drugset / Trial / NCT07551843
Comparative Effects of Autologous Serum, Umbilical Cord Blood-Derived Drops, and Platelet Lysate on Ocular Surface Parameters
Phase 1/2
Completed
80 enrolled
G.Gennimatas General Hospital
Biomedical Research Foundation, Academy of Athens · collab
RandomizedParallel-groupOpen-labelSupportive care
Summary
In this study, patients are randomly assigned to the study groups (autologous peripheral blood, umbilical cord blood, autologous serum). Each patient, who wishes to undergo any treatment, has the right to be informed about their disease and the recommended treatment by the treating physician so that they can decide whether to proceed with it or not. During the study, you will need to complete an eye symptom assessment questionnaire (Ocular Surface Disease Index - OSDI).
Timeline
- Start
- 2023-10-17
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Autologous Platelet Lysate | Unknown | — | Other |
| Comparator | Autologous serum | Unknown | — | Other |
| Comparator | Umbilical Cord Blood Platelet Lysate | Unknown | — | Other |